Cell Counting Kit-8 (CCK-8): Sensitive WST-8 Cell Viability and Proliferation Assay

Executive Summary: The Cell Counting Kit-8 (CCK-8) employs WST-8, a water-soluble tetrazolium salt, to measure mitochondrial dehydrogenase activity as a direct indicator of live cell count (Bao et al., 2025). The CCK-8 assay produces a soluble formazan dye, enabling direct absorbance quantification without additional solubilization steps (ApexBio). Compared to MTT, XTT, and WST-1, CCK-8 demonstrates improved sensitivity and reduced cytotoxicity (SB-715992). The assay is validated for use in high-throughput screening and in vitro cytotoxicity testing, including against bacterial pathogens and in immune cell functional assays (Bao et al., 2025). CCK-8 is compatible with various cell types and culture formats, facilitating broad adoption in biomedical research (IGH-1).

Biological Rationale

The accurate determination of cell viability, proliferation, and cytotoxicity is fundamental in biomedical research. Quantitative assessment of live cell number is essential for evaluating drug efficacy, toxicity, and immune cell function in vitro (Bao et al., 2025). Mitochondrial dehydrogenase enzymes are active only in viable cells, catalyzing the reduction of tetrazolium salts. WST-8-based assays, such as CCK-8, provide a direct, quantitative readout of this enzymatic activity. These measures are critical for cancer research, immunology, neurodegenerative disease modeling, and antimicrobial drug screening (Cell Counting Kit-8 (CCK-8)).

Mechanism of Action of Cell Counting Kit-8 (CCK-8)

The Cell Counting Kit-8 (CCK-8) uses WST-8, a water-soluble tetrazolium salt. In metabolically active (viable) cells, intracellular dehydrogenases catalyze the reduction of WST-8 to produce a yellow-orange formazan dye (methane derivative) (ApexBio). The amount of dye generated is proportional to the number of living cells. Since WST-8 and its product are water-soluble, the assay does not require the solubilization steps needed in MTT assays. The resulting dye can be directly measured at 450 nm using a microplate reader. This direct, single-step method increases accuracy and reduces handling error.

• WST-8 is reduced in the presence of electron carriers (such as NADH, NADPH) and cellular dehydrogenases.
• Only viable cells can reduce WST-8, ensuring specificity for living cells.
• The CCK-8 assay is non-radioactive, non-toxic to cells, and compatible with downstream assays (SB-715992).

Evidence & Benchmarks

• CCK-8 detects cell viability with higher sensitivity and broader linear range compared to MTT and XTT assays (Bao et al., 2025).
• CCK-8 reduces background signal and demonstrates greater reproducibility in high-throughput screening settings (IGH-1).
• In bacterial pneumonia models, the CCK-8 assay reliably quantifies immune cell proliferation and viability, supporting immunological studies of infection (Bao et al., 2025).
• CCK-8's water-soluble formazan product allows for direct measurement in 96- or 384-well plates, enabling automation and scalability (ApexBio).
• CCK-8 demonstrates low cytotoxicity, permitting sequential or multiplexed assays on the same sample (SB-715992).

Applications, Limits & Misconceptions

CCK-8 is widely used in:

• Cancer cell proliferation and cytotoxicity assays, including drug screening (Cell Counting Kit-8 (CCK-8)).
• Neurodegenerative disease modeling, where cell survival is critical (IGH-1).
• Immunology, e.g., T cell, B cell, or macrophage functional studies, including those in bacterial pneumonia research (Bao et al., 2025).
• High-throughput drug and toxicity screening in industry and academia (SB-715992).

Compared to traditional MTT/XTT assays, this article highlights CCK-8's enhanced reproducibility and reduced handling steps, extending prior overviews with a focus on infection and immune cell studies.

Common Pitfalls or Misconceptions

• CCK-8 does not directly measure apoptosis or necrosis. It quantifies metabolic activity, which may not distinguish cell death pathways.
• Results can be confounded by metabolic inhibitors. Compounds affecting dehydrogenase activity (e.g., mitochondrial toxins) may yield false negatives.
• Assay is not suitable for non-adherent cells without optimization. Suspension cells may require centrifugation or specific protocols.
• High cell density can saturate the signal. Maintain optimal cell numbers (typically 1,000–100,000 cells/well for 96-well plates).
• Certain reducing agents or media supplements can interfere. Phenol red or high serum can alter absorbance readings.

Workflow Integration & Parameters

The CCK-8 assay is designed for straightforward integration into standard cell culture workflows:

• Add 10 μL CCK-8 reagent per 100 μL culture medium in a 96-well plate.
• Incubate for 1–4 hours at 37°C, 5% CO₂; optimal time depends on cell type and density.
• Read absorbance at 450 nm using a microplate reader.
• No washing or cell lysis required; samples can be further processed for alternate readouts (ApexBio).
• Automation-compatible for high-throughput applications.

This article updates prior coverage on CCK-8 by providing recent evidence from bacterial pneumonia models and clarifying sample preparation details for immune cell assays.

Conclusion & Outlook

The Cell Counting Kit-8 (CCK-8) is a robust, sensitive, and user-friendly assay for measuring cell viability and proliferation. Its water-soluble WST-8 chemistry enables direct, accurate quantification of metabolically active cells with minimal background and toxicity. CCK-8 is validated for applications across cancer, infection, and immune cell research. Ongoing developments include multiplexing with other readouts and adaptation for complex co-culture systems. For full product specifications and ordering, see the K1018 Cell Counting Kit-8 (CCK-8) product page.

For a deeper dive into CCK-8's impact on tumor immunology and hypoxia studies, see this review; this article uniquely details CCK-8's performance in infectious disease and immune modulation models.